Literature DB >> 8697621

Significance of anti-nuclear and anti-extracellular matrix autoantibodies for albuminuria in murine lupus nephritis; a longitudinal study on plasma and glomerular eluates in MRL/l mice.

M C van Bruggen1, C Kramers, M N Hylkema, R J Smeenk, J H Berden.   

Abstract

The relationship between autoantibody reactivities and nephritis in systemic lupus erythematosus (SLE) is unclear. We studied MRL/l mice which developed a considerable albuminuria (either mice with short ( < 1 week) or heavy and prolonged (3 weeks) albuminuria) and compared them with non-albuminuric age-matched controls, with young (12 weeks old) non-albuminuric mice and with mice which were followed for 36 weeks and did not develop albuminuria. In a longitudinal prospective study on plasma samples we correlated a variety of anti-nuclear reactivities and reactivities against extracellular matrix (ECM) components, with the onset of albuminuria. We found that at the onset of albuminuria, anti-DNA was higher while anti-nucleosome and anti-H2A/H2B-DNA subnucleosome reactivities were lower compared with age-matched non-albuminuric mice. We also studied glomerular eluates of these mice in ELISA and in indirect immunofluorescence (IF). In the eluates we found with IF that anti-glomerular basement membrane (GBM)-tubular basement membrane (TBM) antibodies were already present in 12-week-old non-albuminuric mice. These eluates showed no anti-nuclear antibodies. In eluates of albuminuric mice more immunoglobulin was deposited, and anti-ECM, anti-DNA and anti-nucleosome reactivities were higher than in eluates of age-matched non-albuminuric mice. The deposition of anti-nucleosome antibodies preceded the deposition of anti-DNA antibodies since they were deposited to a greater extent in mice with a short albuminuria. We conclude that anti-GBM-TBM antibodies are the first autoantibodies that deposit in glomeruli of MRL/l mice at an early age. The onset of albuminuria is associated with additional deposition of both anti-ECM and anti-nuclear (anti-nucleosome and anti-DNA) antibodies, but the difference with non-albuminuric mice seems to be more quantitative than qualitative.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8697621      PMCID: PMC2200474          DOI: 10.1046/j.1365-2249.1996.d01-731.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  15 in total

1.  Nephritogenic lupus antibodies recognize glomerular basement membrane-associated chromatin fragments released from apoptotic intraglomerular cells.

Authors:  Manar Kalaaji; Elin Mortensen; Leif Jørgensen; Randi Olsen; Ole Petter Rekvig
Journal:  Am J Pathol       Date:  2006-06       Impact factor: 4.307

Review 2.  The pathogenesis and diagnosis of systemic lupus erythematosus: still not resolved.

Authors:  Ole Petter Rekvig; Johan Van der Vlag
Journal:  Semin Immunopathol       Date:  2014-04-25       Impact factor: 9.623

Review 3.  The anti-DNA antibody: origin and impact, dogmas and controversies.

Authors:  Ole P Rekvig
Journal:  Nat Rev Rheumatol       Date:  2015-06-02       Impact factor: 20.543

Review 4.  Glomerular antibodies in lupus nephritis.

Authors:  Catherine Hanrotel-Saliou; Isabelle Segalen; Yannick Le Meur; Pierre Youinou; Yves Renaudineau
Journal:  Clin Rev Allergy Immunol       Date:  2011-06       Impact factor: 8.667

5.  Isolation of anti-nucleosome antibodies from the plasma of lupus nephritis patients.

Authors:  R Suenaga; K Mitamura; N I Abdou
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

Review 6.  Lupus nephritis: enigmas, conflicting models and an emerging concept.

Authors:  Natalya Seredkina; Johan Van Der Vlag; Jo Berden; Elin Mortensen; Ole Petter Rekvig
Journal:  Mol Med       Date:  2013-07-24       Impact factor: 6.354

Review 7.  Lupus nephritis: the central role of nucleosomes revealed.

Authors:  Elin S Mortensen; Kristin A Fenton; Ole P Rekvig
Journal:  Am J Pathol       Date:  2008-01-10       Impact factor: 4.307

8.  Relationship between antinuclear antibody and microalbuminuria in the general population: the Takahata study.

Authors:  Mizue Ishikawa; Tsuneo Konta; Zhimei Hao; Satoshi Takasaki; Hiroshi Abiko; Toshiyuki Takahashi; Ami Ikeda; Kazunobu Ichikawa; Yoko Shibata; Yasuchika Takeishi; Takeo Kato; Sumio Kawata; Isao Kubota
Journal:  Clin Exp Nephrol       Date:  2008-02-13       Impact factor: 2.801

9.  Clinical significance of antinucleosome antibodies in Tunisian systemic lupus erythematosus patients.

Authors:  S Haddouk; M Ben Ayed; S Baklouti; J Hachicha; Z Bahloul; H Masmoudi
Journal:  Clin Rheumatol       Date:  2004-11-16       Impact factor: 3.650

Review 10.  Chromatin as a target antigen in human and murine lupus nephritis.

Authors:  Annica Hedberg; Elin Synnøve Mortensen; Ole Petter Rekvig
Journal:  Arthritis Res Ther       Date:  2011-04-18       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.